Fingerprint
Dive into the research topics of 'Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: A gynecologic oncology group study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: A gynecologic oncology group study
David Scott Miller, John A. Blessing, Samuel S. Lentz, D. Scott McMeekin, Denise Mackey
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations